EP0334507A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid
Assignee: Scotia Holdings PLC
•
Filing: 1989-03-07
•
Granted: —
•
Expires: 2009-03-07
Abstract
Abstract A composition, particularly an oral composition, for improving the smoothness of the skin, wherein GLA or DGLA or both as such or in the form of physiologically acceptable and equivalent derivatives are brought into administrable form with a carrier or diluent.
Inventors
- 👤 David F. c/o Scotia Pharma. Ltd. Horrobin
- 👤 John C. M. c/o Scotia Pharma. Ltd. Stewart
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-07 04:46
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/60; A61K8/33; A61K8/36; A61K8/361; A61K31/00; A61K31/185; A61K31/19; A61K31/20; A61K8/67; A61P; A61P3/00; A61P3/06; A61Q; A61Q19/00; A61K2800/00; A61K2800/80; A61K2800/92
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
37 words
The use of GLA or DGLA or both as such or in the form of physiologically acceptable and equivalent derivatives for the manufacture of a medicament, particlularly an oral medicament, for improving the smoothness of the skin.
Claim 2
Dependent Claim
37 words
The use of GLA or DGLA or both as such or in the form of physiologically acceptable and equivalent derivatives for the manufacture of a medicament, particlularly an oral medicament, for improving the smoothness of the skin.
Claim 3
Dependent Claim
41 words
A composition, particularly an oral composition, for improving the smoothness of the skin, wherein GLA or DGLA or both as such or in the form of physiologically acceptable and equivalent derivatives are brought into administrable form with a carrier or diluent.
Claim 4
Dependent Claim
41 words
A composition, particularly an oral composition, for improving the smoothness of the skin, wherein GLA or DGLA or both as such or in the form of physiologically acceptable and equivalent derivatives are brought into administrable form with a carrier or diluent.
Claim 5
Dependent Claim
55 words
The use of claim 1 or the composition of claim 2 wherein the amounts of GLA and/or DGLA are suited to administration, particularly oral administration, of 1 mg to 100 g, preferably 20 mg to 2g, more preferably 1 mg to 500 mg, of the or each acid or molar equivalent amounts of derivative(s) daily.
Claim 6
Dependent Claim
50 words
A composition as claimed in claim 2, for topical use, in which the acid(s) are present in a concentration of 0.001 to 20% by weight, preferably 0.01 to 10% by weight and more preferably 0.05 to 3% by weight, of the or each acid or molar equivalent amount(s) or derivative(s).
Claim 7
Dependent Claim
40 words
A method of improving the smoothness of the skin by administering, particularly administering orally, GLA or DGLA or both as such or in the form of physiologically acceptable and equivalent derivatives in the daily amount set out in claim 3.
Claim 8
Dependent Claim
38 words
A method of improving the smoothness of the skin by application of the composition of claim 4 to the skin in an amount to give the daily amount of the acid(s) or derivative(s) set out in claim 3.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.